Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C548651 |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester |
2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of EPHB3 mRNA | decreases expression | 19933214
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of EPHB3 mRNA | affects expression | 17562736
|
D015081 |
2-Naphthylamine |
2-Naphthylamine results in increased expression of EPHB3 mRNA | increases expression | 18247414
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of EPHB3 mRNA | decreases expression | 18247414
|
D008769 |
Methylnitronitrosoguanidine |
Methylnitronitrosoguanidine results in decreased expression of EPHB3 mRNA | decreases expression | 12634122
|
C406082 |
monomethylarsonous acid |
monomethylarsonous acid results in decreased expression of EPHB3 mRNA | decreases expression | 20024957
|
D009538 |
Nicotine |
Nicotine results in decreased expression of EPHB3 mRNA | decreases expression | 18247414
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of EPHB3 mRNA | decreases expression | 19933214
|
D014212 |
Tretinoin |
Tretinoin affects the expression of EPHB3 mRNA | affects expression | 16251210
|
D014302 |
Trinitrobenzenesulfonic Acid |
Trinitrobenzenesulfonic Acid results in increased expression of EPHB3 mRNA | increases expression | 17982090
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.08 | 15322242 11752688 14514962 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
2.02 | 20127859 20464547 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.74 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
3.61 | 16835633 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.75 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
3.31 | 16627626 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.11 | 11748828 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
4.11 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
4.29 | 19183758 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.18 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.30 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.39 | 16456186 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.41 | 18445737 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.60 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.52 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
9.52 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.06 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.87 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
1.80 | 20146248 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.80 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
1.80 | 16166294 16443354 16873071 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.83 | 16813970 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.93 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.42 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
2.93 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
2.93 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
4.71 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.71 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.45 | 18670907 18850075 16120746 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
7.54 | 10977129 |
MESH:D002386 |
Cataract |
|
Tretinoin |
7.54 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitronitrosoguanidine |
7.92 | 2727394 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
monomethylarsonous acid |
7.92 | 19716837 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.83 | 16129372 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.31 | 16835633 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.42 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.98 | 16354765 15340226 15668235 8697196 12621046 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.98 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
10.51 | 17035595 |
MESH:D003092 |
Colitis |
|
Trinitrobenzenesulfonic Acid |
10.51 | 18023891 18200517 16867261 16474422 17936198 16782535 11698051 16804969 17991707 |
MESH:D003093 |
Colitis, Ulcerative |
|
Trinitrobenzenesulfonic Acid |
3.49 | 17276891 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
2.49 | 20055451 10048152 15322242 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
2.49 | 9125849 17551590 9211117 16925845 9664655 10589399 14991402 9142499 9224671 8800419 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.70 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
3.70 | 16781746 11743745 11834606 11739529 14725611 12153990 11461765 2444490 18071297 12540782 19416960 10774834 14986274 14550746 19739265 11529661 15968718 12594235 10915739 19923254 11421492 19164858 17522070 19420014 11287661 17906064 12705907 18713872 16227642 10663392 16177239 15619225 16081117 12392966 16109766 12958197 17562736 19085960 16485898 19370779 16393943 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.70 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
4.36 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.89 | 11462148 |
MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
6.16 | 17881519 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
2.55 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
12.85 | 18230668 15322242 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
12.85 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.21 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.18 | 9294722 10568697 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
2.04 | 16530937 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
9.26 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
9.26 | 16938888 9664655 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.67 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
16.19 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
16.19 | 17994277 |
MESH:D005355 |
Fibrosis |
|
Trinitrobenzenesulfonic Acid |
16.19 | 17994277 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.94 | 16983495 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.11 | 17312396 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.86 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.29 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.42 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
11.57 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
11.57 | 11294989 10048152 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
11.57 | 9664655 14991402 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.51 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
3.11 | 15340226 12621046 16120746 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.31 | 16959395 18606429 8697196 16354765 15340226 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
8.09 | 16870215 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
8.09 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.78 | 16778211 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.96 | 18850075 18670907 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
1.93 | 12200463 12878042 |
MESH:D015212 |
Inflammatory Bowel Diseases |
|
Trinitrobenzenesulfonic Acid |
3.63 | 18200517 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
10.72 | 17994277 |
MESH:D007410 |
Intestinal Diseases |
|
Trinitrobenzenesulfonic Acid |
10.72 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
10.51 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
10.51 | 15992940 17551590 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
2.29 | 15629191 12587719 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.84 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.87 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.10 | 16294345 17596541 19850784 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.26 | 17301526 16891316 17368321 17107899 16140955 17361223 19225113 16823087 12679006 17294898 17506722 16788101 19029980 17712046 17217047 17339181 16935935 17649720 16331271 19075265 15748426 19642359 16766008 19035177 9834237 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.43 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
2.35 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
2.35 | 18397230 16248980 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
1.66 | 19014921 19784758 12969438 16611625 19460945 16610002 12587719 11587558 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.40 | 16871587 17185352 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
4.52 | 20195826 21137059 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
4.52 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.20 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
2.22 | 17053015 18816296 6695378 18569708 20869020 20464547 20064080 20135361 18520028 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.22 | 19555203 11884234 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.84 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.96 | 16752155 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.78 | 19513568 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.64 | 16940565 |
MESH:D053842 |
Microsatellite Instability |
|
Methylnitronitrosoguanidine |
6.13 | 17671175 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
3.32 | 16381670 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.17 | 17596541 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.16 | 12213967 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
8.87 | 11141357 |
MESH:D009369 |
Neoplasms |
|
Nicotine |
8.87 | 16365874 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
8.87 | 16594593 16946489 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
5.23 | 16365874 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
10.18 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
10.18 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.16 | 9142499 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
3.01 | 18514411 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
2.39 | 16936753 |
MESH:D010146 |
Pain |
|
Acetaminophen |
7.07 | 16870215 |
MESH:D010146 |
Pain |
|
Tretinoin |
7.07 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.51 | 15976015 |
MESH:D010195 |
Pancreatitis |
|
Trinitrobenzenesulfonic Acid |
4.38 | 17698068 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.51 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.76 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.43 | 11896295 11399792 11118676 11222880 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
2.94 | 17292933 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.79 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.03 | 16723453 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.04 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.28 | 16283617 16116481 |
MESH:D012640 |
Seizures |
|
Nicotine |
3.91 | 17873105 |
MESH:D012871 |
Skin Diseases |
|
monomethylarsonous acid |
3.41 | 17431481 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
9.82 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.82 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.82 | 16467112 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.38 | 2093021 20155912 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.38 | 17261132 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.17 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
3.15 | 16026305 17045167 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.85 | 16785264 11259349 16720336 |
MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
5.66 | 15735609 17979512 18305452 18041664 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.95 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.33 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Naphthylamine |
8.97 | 11144890 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
8.97 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
monomethylarsonous acid |
8.97 | 20375083 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
3.16 | 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.84 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.88 | 16752155 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.86 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.25 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.51 | 15886252 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.12 | 16287080 |